Invasive Fungal Sinusitis: Risk Factors for Visual Acuity Outcomes and Mortality.

PURPOSE Invasive fungal sinusitis is a rare but potentially lethal disease that primarily affects immunocompromised patients. The purpose of this study was to review an academic medical center's experience in the presentation, diagnosis, and treatment of invasive fungal sinusitis. METHODS A retrospective chart review was performed at a single institution over a 17-year period. Medical records, radiographic imaging, and operative reports were analyzed. Bivariate and multivariable analyses were performed to determine factors that affected visual acuity outcomes and mortality. RESULTS Fifty-five patients with histopathologically confirmed invasive fungal sinusitis were included. The average duration of follow up was 1.8 ± 2.6 years (range: 1 week to 10 years). The most common causes of immunosuppression were hematologic malignancy (45%), diabetes (31%), and organ transplantation (9%). At presentation, 35% of individuals were neutropenic (absolute neutrophil count < 500/μl). All patients received systemic antifungal treatment. A surgical intervention was performed on 50 patients (91%), and all but one had functional endoscopic sinus surgery. Nine (16%) patients underwent orbital exenteration. Multivariable analysis of visual acuity outcomes demonstrated that individuals infected with Zygomycota had 6-7 lines worse vision than those infected with Ascomycota (mean difference in logMAR 0.66, 95% confidence interval 0.27 to 1.06, p = 0.001). Patients who had functional endoscopic sinus surgery had 7-8 lines better visual acuity than those without functional endoscopic sinus surgery (mean difference in logMAR -0.76, 95% confidence interval -1.13 to -0.38, p < 0.001). The overall death rate due to infection was 24%. Bivariate models demonstrated no difference in mortality in patients receiving exenteration versus those who did not (p = 0.14). Multivariable analysis of mortality demonstrated that neutropenia increased mortality (adjusted odds ratio 10.05, 95% confidence interval 1.49 to 67.67, p = 0.02). Having a greater number of surgeries was associated with an increased rate of survival (adjusted odds ratio 0.39, 95% confidence interval 0.15 to 0.96, p = 0.04). CONCLUSIONS Invasive fungal sinusitis is an aggressive disease with significant mortality. Patients with neutropenia had a lower rate of survival, and infection with Zygomycota was associated with worse visual acuity outcomes. Those having functional endoscopic sinus surgery had better final visual acuity, and an increased number of surgeries was associated with a decreased chance of death. Exenteration yielded no observed survival benefit.

[1]  M. Vagefi,et al.  Invasive fungal sinusitis: treatment of the orbit , 2017, Current opinion in ophthalmology.

[2]  M. Vagefi,et al.  Retrobulbar Injection of Amphotericin B for Orbital Mucormycosis. , 2017, Ophthalmic plastic and reconstructive surgery.

[3]  Z. Joos,et al.  Intraorbital Irrigation of Amphotericin B in the Treatment of Rhino-Orbital Mucormycosis. , 2017, Ophthalmic plastic and reconstructive surgery.

[4]  K. Rezvani,et al.  Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection , 2016, Virulence.

[5]  T. Hohl,et al.  Role of Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Regulating Neutrophil Antifungal Activity and the Oxidative Burst During Respiratory Fungal Challenge. , 2016, The Journal of infectious diseases.

[6]  Lauren T. Roland,et al.  Acute Invasive Fungal Rhinosinusitis , 2016, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[7]  Michael J. Richard,et al.  The Role of Adjunctive Therapies in the Management of Invasive Sino-Orbital Infection , 2015, Ophthalmic plastic and reconstructive surgery.

[8]  E. Holbrook,et al.  Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and Aspergillus , 2015, British Journal of Ophthalmology.

[9]  Timothy L. Smith,et al.  Invasive Fungal Rhinosinusitis , 2013, The Laryngoscope.

[10]  J. Turner,et al.  Survival outcomes in acute invasive fungal sinusitis: A systematic review and quantitative synthesis of published evidence , 2013, The Laryngoscope.

[11]  D. R. Jordan,et al.  Orbital Apergillosis Treated with Retrobulbar Amphotericin B , 2012, Orbit.

[12]  J. Perfect The impact of the host on fungal infections. , 2012, The American journal of medicine.

[13]  Nina Singh,et al.  Immune reconstitution syndrome and fungal infections , 2011, Current opinion in infectious diseases.

[14]  A. Süslü,et al.  Acute invasive fungal rhinosinusitis: our experience with 19 patients , 2008, European Archives of Oto-Rhino-Laryngology.

[15]  T. Wakabayashi,et al.  Retrobulbar Amphotericin B Injections for Treatment of Invasive Sino-orbital Aspergillosis , 2007, Japanese Journal of Ophthalmology.

[16]  B. Haik,et al.  Indications for Orbital Exenteration in Mucormycosis , 2006, Ophthalmic plastic and reconstructive surgery.

[17]  J. DelGaudio,et al.  Invasive Fungal Sinusitis: A 15-Year Review from a Single Institution , 2004, American journal of rhinology.

[18]  B. Patel,et al.  Successful Treatment of Rhino-orbital Mucormycosis Without Exenteration: The Use of Multiple Treatment Modalities , 2001, Ophthalmic plastic and reconstructive surgery.

[19]  S. Seiff,et al.  Role of local amphotericin B therapy for sino-orbital fungal infections. , 1999, Ophthalmic plastic and reconstructive surgery.

[20]  C. Juárez,et al.  Intraconal amphotericin B for the treatment of rhino-orbital mucormycosis. , 1996, Ophthalmic surgery and lasers.

[21]  G. Harris,et al.  Orbital aspergillosis. Conservative debridement and local amphotericin irrigation. , 1988 .

[22]  C. Haudenschild,et al.  Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro. , 1980, The Journal of clinical investigation.